
Conference Coverage
about 1 month ago
Why Patient Voices Matter: A Liver Cancer Advocate at ASCOLatest Content

What Writing My Mom's Obituary Taught Me as a Cancer Survivor

Lung Cancer Advocacy: The Importance of Support, Awareness and Community

Lung Cancer Treatments Explained: How Chemotherapy, Targeted Therapy and Immunotherapy Work

This Oncology Nurse Stayed by Her Patient's Side Until His Very Last Days

A New Frontier in Small Cell Lung Cancer: What Patients Need to Know

Shorts










Podcasts
Videos
All News

Janet Fuller, DNP, RN, OCN, of Vanderbilt University Medical Center, helped two young breast cancer patients form a support group that now guides dozens of women through diagnosis and treatment.

A decade after my double mastectomy, I went to the cardiologist worried about my heart and left having shared my breast cancer story with a stranger.

Three years after ringing the bell for lymphoma, the cancer came back in my brain. Choosing hospice care was the hardest decision I have ever had to make.

Long-term follow-up of a trial found patients with recurrent prostate cancer lived longer after receiving the pTVG-HP vaccine than GM-CSF alone.

ASCO updated its guideline to recommend broader first-line HER2-targeted treatment options, with immunotherapy for eligible patients with PD-L1 expression of 1% or higher.

Cancer drugs sit in a protected class under Medicare Part D, but plans can still deny coverage. A researcher from Vanderbilt found that many of those denials do not hold up under outside review.

Andrew Evens, DO & Joanna Rhodes, MD on CLL's transformation, CAR-T vs bispecifics, Hodgkin survivorship, and delivering world-class lymphoma care across New Jersey.

In five months, we lost the land, the travel and the retirement we had planned together, and then learned my husband's lymphoma had come back in his brain.

Cat-camel exercises can gently improve spine mobility and comfort. Learn how this simple movement can support flexibility during cancer recovery.

In the phase 2 SANRECO trial, 88% of patients with polycythemia vera kept hematocrit below 45% without a phlebotomy. Lead investigator Dr. Marina Kremyanskaya explains what that could mean day to day.

Adding the personalized mRNA therapy intismeran autogene to Keytruda cut melanoma recurrence and spread risk after surgery, a Phase 3 trial found.

Juanita Segura shares her nearly 12-year lung cancer journey, the power of community and why she advocates for biomarker testing and hope.

Learn what lung cancer stages mean, why biomarker testing matters, and how advances in precision medicine are changing treatment for patients.

In the phase 2 KEYPAD trial, Keytruda plus Xgeva shrank tumors in 31% of patients with advanced clear cell kidney cancer after prior treatment.

Leslie Waltke demonstrates gentle trunk rotations to help improve mobility in the lower and upper spine. Learn how to safely perform this exercise at home.





















